ROBERTS EIRY
Related Filers (2)
Other (7)
144
Tuesday, 2/13/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 2/6/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/31/2024
Filing for proposed sale of securities under Rule 144
144
Friday, 12/22/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/6/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/22/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 4/24/2023
Filing for proposed sale of securities under Rule 144
Ownership (35)
4
Thursday, 2/15/2024
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/8/2024
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/2/2024
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/27/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/14/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 12/11/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 12/8/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/23/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
AMICUS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/26/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 4/26/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/15/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/8/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
AMICUS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/9/2022
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/2/2022
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/12/2022
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
3
Monday, 6/14/2021
AMICUS THERAPEUTICS, INC.: Initial statement of beneficial ownership of securities
4
Monday, 6/14/2021
AMICUS THERAPEUTICS, INC.: Statement of changes in beneficial ownership of securities
4/A
Monday, 3/29/2021
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/12/2021
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Monday, 11/16/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 8/7/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/25/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/28/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/11/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/7/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 1/10/2020
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Friday, 2/8/2019
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Thursday, 1/10/2019
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/7/2018
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/10/2018
NEUROCRINE BIOSCIENCES INC: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/10/2018
NEUROCRINE BIOSCIENCES INC: Initial statement of beneficial ownership of securities